The information you are about to be referred to may not comply with Australian regulatory requirements.
Information in this website is general information only. Please speak to a healthcare professional for any medical advice.
PM-AU-AVX-WCNT-190056 Date of GSK Approval: January 2021
The information you are about to be referred to may not comply with the Australian regulatory requirements.
Further information relevant to the Australian environment is available from the company.
For a better experience, keep your browser up-to-date.
Skip to main content
Learn about shingles, what it is, its signs, symptoms, potential complications and who is at risk.
Learn about various infectious diseases; the risks, signs, symptoms, treatment and preventative options.
Learn about meningococcal disease, what is it, its signs, symptoms and who is at risk.
You might find these infectious diseases and travel advice sites handy too. Or for further information please speak to your Healthcare Professional.
NP-AU-AVX-WCNT-210001 Date of GSK Approval: December 2021
Back to top
Connect with GSK
© 2020 GSK group of companies or its licensor. GlaxoSmithKline Australia Pty Ltd. ABN 47 100 162 481. Melbourne, VIC
PM-AU-AVX-WCNT-190057 Date of GSK Approval: May 2021